New MRI Scans to Assess Fatty Liver Disease Without Needle Biopsy
Uses new MRI scans to study fatty liver disease linked to metabolism in patients.
Plain-language title generated from the registry record
Registry title: To Explore the Value of New MR Technology in Non-invasive Quantitative Assessment of Systemic Metabolism, Disease Status and Prognosis in Patients With Metabolic-Associated Fatty Liver Disease
Key facts
- Where
- Wuhan, ChinaSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people who are suspected of having or already have metabolism-related fatty liver disease and are having an MR scan. They must agree to take part and sign a consent form.
- Age
- No age limit.
- Sex
- Men and women can join.
- Disease stage
- Suspected or diagnosed metabolism-related fatty liver disease.
Read by machine on 9 November 2026.
Where in China
- Tongji HospitalWuhan, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Tongji Hospital
- Trial code
- NCT07149571
- Record updated
- 2 September 2025
- Original description
The purpose of this study is to explore the value of new MR technology in assessing the systemic metabolism, disease status, and prognostic risk of metabolism-related fatty liver disease. By obtaining clinical, imaging, laboratory examination and pathological data of metabolism-related fatty liver disease, image processing software is used to analyze the images, explore the relationship between imaging parameters, body composition and metabolic diseases and metabolism-related fatty liver disease, and achieve non-invasive diagnosis, efficacy evaluation, and prognosis prediction of metabolism-related fatty liver disease. Thereby guiding clinical treatment and improving the prognosis and quality of life of patients with metabolism-related fatty liver diseaseRead full original descriptionShow less
To Explore the Value of New MR Technology in Non-invasive Quantitative Assessment of Systemic Metabolism, Disease Status and Prognosis in Patients With Metabolic-Associated Fatty Liver Disease
The purpose of this study is to explore the value of new MR technology in assessing the systemic metabolism, disease status, and prognostic risk of metabolism-related fatty liver disease. By obtaining clinical, imaging, laboratory examination and pathological data of metabolism-related fatty liver disease, image processing software is used to analyze the images, explore the relationship between imaging parameters, body composition and metabolic diseases and metabolism-related fatty liver disease, and achieve non-invasive diagnosis, efficacy evaluation, and prognosis prediction of metabolism-related fatty liver disease. Thereby guiding clinical treatment and improving the prognosis and quality of life of patients with metabolism-related fatty liver disease
Inclusion: Patients with MR examination are clinically suspected or diagnosed with metabolism-related fatty liver disease; Age/gender: unlimited; Patients who voluntarily participate in clinical trials and sign written subject informed consent.
Exclusion: Clinical suspicion or diagnosis of metabolism-related fatty liver disease and having been prescribed an MR examination; Voluntarily participation in the study and provision of written informed consent.